antibodi
conserv
stem
region
ha
block
membran
fusion
prevent
product
infect
divers
influenza
virus
structur
basi
ha
stem
recognit
two
monoclon
antibodi
antibodi
bind
nanomolar
affin
highli
conserv
hydrophob
groov
interfac
two
polypeptid
constitut
ha
neutral
sever
influenza
group
subtyp
includ
ref
among
antistem
antibodi
isol
far
gene
segment
observ
frequent
expect
understand
develop
antibodi
studi
prototyp
broadli
neutral
antibodi
isol
phage
display
human
immunoglobulin
gene
well
two
other
clone
singl
human
cell
ref
influenza
broadli
neutral
antibodi
undergo
rel
low
degre
somat
mutat
averag
amino
acid
heavi
chain
n
fig
first
ask
whether
germlin
antibodi
precursor
might
recogn
ha
measur
affin
notabl
germlin
ancestor
fail
bind
ha
solubl
igg
even
concentr
high
fig
defin
molecular
basi
affin
matur
antibodi
analys
respect
contribut
heavi
light
chain
antigen
recognit
compar
chimaer
antibodi
consist
somat
heavi
sh
germlin
light
gl
chain
matur
antibodi
shsl
chimaer
shgl
three
antibodi
bound
recombin
ha
affin
similar
respect
matur
shsl
fig
matur
light
chain
thu
affect
bind
ha
rather
somat
mutat
heavi
chain
gene
alon
mediat
increas
bind
affin
find
consist
lack
lightchain
interact
observ
crystal
structur
suggest
lightchain
somat
mutat
may
incident
requir
pair
improv
neutral
function
next
investig
minimum
requir
heavychain
loop
matur
lead
somat
activ
chose
focu
analysi
first
antistem
broadli
neutral
antibodi
discov
structur
known
sh
differ
germlin
heavi
gh
chain
amino
acid
fig
four
amino
acid
pro
arg
ly
phe
contact
ha
stem
crystal
structur
fig
gener
sever
germlin
variant
introduc
residu
sh
includ
cdr
cdr
cdr
gh
singli
combin
result
antibodi
analys
abil
bind
ha
neutral
viru
hapseudotyp
lentivir
tabl
test
individu
somat
cdr
scdr
increas
bind
less
sh
furthermor
scdr
alon
confer
detect
activ
neutral
assay
tabl
although
alon
improv
potenc
germlin
scdr
togeth
restor
full
activ
bind
neutral
virus
tabl
fig
supplementari
fig
find
suggest
mutat
small
number
germlin
residu
enabl
potent
neutral
cdr
sit
adjac
one
anoth
fold
protein
examin
protein
structur
antibodi
cdr
mutat
phe
buri
canon
conform
cdr
ref
contrast
somat
mutat
cdr
flip
hydrophob
residu
phe
place
residu
contact
ha
determin
whether
posit
phe
due
matur
bind
solv
crystal
structur
unligand
shgl
compar
antibodi
mutat
cdr
haligand
fig
unligand
structur
phe
expos
surfac
suggest
somat
mutat
lead
placement
hydrophob
residu
interior
antibodi
made
avail
contribut
interfac
mutat
adjac
residu
cdr
germlin
affinitymatur
state
well
order
unless
bound
antigen
howev
cdr
loop
favour
noncanon
conform
phe
expos
whether
ha
bound
solv
structur
suggest
main
consequ
somat
cdr
mutat
favour
noncanon
state
comparison
structur
also
explain
synergist
effect
mutat
cdr
somat
mutat
introduc
phe
surfac
adjac
phe
cdr
two
set
mutat
increas
hydrophob
contact
surfac
either
alon
minim
somat
mutat
germ
line
requir
confer
full
activ
made
surpris
germlin
antibodi
recogn
ha
measur
affin
solut
propos
antibodi
recognit
lowaffin
germlin
revert
requir
physiolog
present
exampl
cell
surfac
antibodi
would
normal
express
natur
bival
transmembran
igm
form
germ
line
transfect
human
embryon
kidney
cell
cell
surfac
express
confirm
stain
antilambdachain
antibodi
fluorescentlabel
ha
stain
cell
mock
transfect
cell
measur
flow
cytometri
fig
contrast
bind
seen
solut
germlin
fab
monom
bival
igg
decamer
igm
antibodi
deriv
supplementari
fig
specif
germlin
bind
ha
stem
confirm
minimum
reactiv
mutant
ha
probe
block
antistemantibodi
bind
supplementari
fig
show
similar
membranedepend
recognit
fig
result
suggest
membran
present
antibodi
provid
mechan
lowaffin
germlin
b
cell
achiev
suffici
bind
recogn
antigen
affin
matur
consist
experi
show
twodimension
confin
cluster
plasma
membran
increas
appar
affin
cell
surfac
two
amino
acid
tip
cdr
ile
phe
seem
anchor
germlin
might
attach
ha
fig
inde
mutat
two
amino
acid
alanin
abolish
ha
germlin
bind
antibodi
fig
individu
mutat
ile
phe
also
abolish
bind
unmodifiedn
ha
trimer
bind
presenc
prevent
sialic
acid
mediat
cell
adhes
fig
supplementari
fig
cocryst
structur
cdr
insert
hydrophob
pocket
ref
fig
data
suggest
interact
germlin
cdr
central
role
recognit
engag
ha
stem
determin
whether
bind
antigen
germlin
antibodi
display
cell
surfac
could
induc
bcr
activ
signal
transmembran
igm
version
germlin
transfect
transform
human
b
cell
capabl
express
function
ramo
cell
clone
whose
endogen
igm
express
method
found
proteoliposomearray
ha
supplementari
fig
select
trigger
tyrosin
phosphoryl
bcr
effector
protein
ref
fig
signal
ha
compar
induc
igm
crosslink
furthermor
mutat
cdr
abolish
respons
ha
stimul
consist
bind
data
confirm
import
germlin
cdr
structur
naiv
bcell
activ
find
indic
engag
lowaffin
germlin
antibodi
lead
bcr
activ
thu
trigger
matur
subsequ
humor
immun
respons
shown
studi
antibodi
mutat
germlineencod
vh
sequenc
engag
influenza
ha
suffici
affin
trigger
bcell
activ
case
engag
depend
membran
present
antibodi
structur
specif
hydrophob
residu
cdr
mutat
analysi
reveal
mutat
convert
germlin
antibodi
full
activ
taken
togeth
result
suggest
germ
line
pois
form
vari
set
cdr
sequenc
broadli
neutral
antibodi
direct
highli
conserv
stem
influenza
ha
antibodi
inher
potenti
recogn
common
featur
influenza
viru
would
seem
offer
obviou
evolutionari
advantag
although
neutral
antibodi
virus
human
immunodefici
viru
hiv
sar
hepat
c
viru
also
use
gene
interact
differ
exampl
antibodi
bind
site
antibodi
bind
ref
orient
cdr
hydrophob
cleft
wherea
other
sar
neutral
antibodi
orient
cdr
hydrophil
case
actual
fold
recogn
cdr
distinct
recogn
ha
stem
togeth
data
suggest
cdr
motif
particularli
well
adapt
recogn
specif
protein
fold
highli
conserv
stem
divers
influenza
viru
germlin
v
h
gene
although
express
part
adapt
immun
respons
may
therefor
serv
primordi
pattern
recognit
receptor
structur
adapt
particip
recognit
hydrophob
heavychain
v
gene
hydrophob
cdr
ref
specul
influenza
may
exert
select
pressur
lead
retent
v
h
gene
also
conceiv
adapt
immun
system
retain
innat
capac
hydrophob
contact
facilit
gener
highaffin
antibodi
limit
degre
somat
mutat
situat
contrast
consider
somat
mutat
observ
broadli
neutral
antibodi
direct
site
recent
evolv
viru
less
opportun
select
protect
antivir
gene
major
current
vaccineelicit
influenza
antibodi
direct
globular
head
region
viral
surfac
glycoprotein
ha
undergo
consider
antigen
drift
evad
human
immun
system
thu
influenza
vaccin
requir
annual
assess
strain
like
circul
come
year
gener
protect
immun
world
popul
consequ
great
interest
develop
univers
influenza
antibodi
target
highli
conserv
ha
stem
epitop
repres
vast
major
broadli
neutral
antibodi
isol
influenza
previous
demonstr
possibl
elicit
stemdirect
antibodi
despit
sequenc
variat
cdr
fr
region
antibodi
evolv
rel
small
number
somat
mutat
time
robust
induct
neutral
antibodi
human
remain
challeng
analysi
current
genom
data
genom
project
reveal
polymorph
allel
contact
site
cdr
leu
replac
phe
predict
homozyg
frequenc
gener
popul
substitut
abolish
ha
recognit
three
germlin
antibodi
supplementari
fig
find
underscor
remark
specif
cdr
contact
rais
possibl
vaccin
recipi
may
mount
respons
time
stem
antibodi
isol
deriv
v
h
gene
remain
possibl
individu
might
develop
respons
igg
loci
taken
togeth
knowledg
initi
engag
ha
stem
v
gene
subsequ
bcr
stimul
somat
mutat
aid
ration
design
univers
influenza
vaccin
gene
encod
wildtyp
ha
protein
anew
nc
ind
somat
mutat
infer
germlin
antibodi
synthes
somat
mutat
germlin
revert
germlin
cdr
ala
mutat
ile
phe
construct
introduc
mutat
germlin
heavi
chain
sitedirect
mutagenesi
plasmid
encod
protein
transfect
human
embryon
kidney
cell
line
isol
express
supernat
h
transfect
ha
trimer
protein
purifi
previous
solubl
fab
igg
igm
antibodi
purifi
use
histrap
protein
g
igm
affin
column
respect
addit
gelexclus
chromatographi
perform
igm
sampl
ge
healthcar
purifi
antibodi
variant
assay
bind
nc
case
ind
enzymelink
immunosorb
assay
elisa
purifi
trimer
ha
protein
variou
antibodi
detect
peroxidaseconjug
goat
antihuman
igg
unless
otherwis
note
endpoint
dilut
determin
nonlinear
fit
curv
use
detect
limit
background
absorb
variant
also
assay
neutral
pseudotyp
recombin
lentivirus
express
wildtyp
ha
correspond
neuraminidas
na
luciferas
report
gene
previous
crystal
structur
shgl
fab
resolut
determin
molecular
replac
method
membran
present
antibodi
germ
line
express
membran
igm
format
cell
subject
facsbas
ha
cell
surfac
bind
assay
h
transfect
method
bcr
trigger
membran
igm
germ
line
transient
express
igmneg
ramo
b
cell
line
expos
proteoliposomearray
nc
method
activ
assess
extent
tyrosin
phosphoryl
use
py
antibodi
gene
encod
ha
protein
anew
nc
genbank
ind
genbank
correspond
neuraminidas
protein
monoclon
antibodi
respect
infer
germlin
synthes
use
human
prefer
codon
geneart
regensburg
germani
germ
line
predict
use
creat
follow
segment
gene
clone
cmvr
vector
effici
express
mammalian
solubl
membran
igm
fab
gene
gener
overlap
pcr
igg
igm
class
switch
region
identifi
sequenc
align
genbank
avail
sequenc
clone
solubl
membranebound
igm
antibodi
mutat
germlin
antibodi
introduc
use
quikchang
sitedirect
mutagenesi
kit
agil
technolog
follow
mutat
germlin
heavi
chain
gener
probe
matur
cdr
cdr
cdr
lack
mutat
amino
acid
cdr
germlin
variant
antibodi
construct
probe
engag
correspond
follow
mutat
cdr
mutat
evalu
role
cell
surfac
present
recognit
lowaffin
antigen
initi
contact
germlin
stage
solubl
germlin
antibodi
express
receptor
igm
surfac
cell
reagent
invitrogen
ha
ligand
nlink
glycan
number
introduc
receptor
bind
site
wildtyp
ha
stem
bind
mutant
mutat
nc
prevent
sialicacidmedi
cell
bind
result
avitag
trimer
biotinyl
purifi
sizeexclus
chromatographi
label
streptavidinlink
pe
two
day
transfect
cell
express
membran
igm
version
germ
line
gl
gl
gl
cdr
mutat
mock
place
ice
stain
violet
fluoresc
reactiv
dye
vivid
catalogu
invitrogen
min
pb
wash
incub
h
pb
contain
fb
either
peha
peha
peantihuman
kappa
chain
catalogu
ebiosci
gl
gl
pe
mous
antihuman
lambda
chain
catalogu
bd
bioscienc
gl
unmodifiedn
ha
bind
cell
incub
trimer
along
mm
prevent
sialicacidmedi
cell
bind
supplementari
fig
h
pb
cell
wash
twice
fix
pb
contain
pfa
vividneg
cell
surfac
pe
intens
quantifi
flow
cytometri
vivid
excit
nm
bandpass
filter
nm
pe
excit
nm
bd
lsr
ii
bd
bioscienc
platform
use
provid
multival
antigen
display
need
oligomer
activ
synapt
engag
architectur
underscor
naiv
bcell
stimul
antigenpres
cell
lymph
node
germin
one
gram
n
iminodiacet
acid
succinyl
avanti
polar
lipid
molar
ratio
evapor
stream
nitrogen
h
dri
lipid
film
rehydr
liposom
buffer
mm
hepe
mm
nacl
ph
hb
shaken
min
time
heat
membran
melt
temperatur
lipid
mixtur
result
homogen
suspens
subject
ten
cycl
extrud
time
pore
polycarbon
membran
use
avanti
miniextrud
avanti
polar
lipid
ha
proteoliposom
produc
incub
result
liposom
histag
nc
trimer
h
room
temperatur
ha
trimer
lipid
molar
ratio
sampl
adjust
iodixanol
ml
hb
overlaid
ml
ml
ml
iodixanol
hb
respect
sampl
centrifug
rotor
sorval
h
proteoliposom
fraction
concentr
iodixanol
interfac
supplementari
fig
collect
dialys
overnight
slidealyz
dialysi
cassett
mwco
catalogu
thermo
scientif
remov
densiti
gradient
materi
dialysi
proteoliposom
pellet
h
rotor
resuspend
hb
measur
pierc
bca
protein
assay
catalogu
thermo
scientif
ramo
b
lymphocyt
atcc
initi
stain
fluoresc
conjug
antilambda
chain
antiigm
monoclon
antibodi
mous
peantihuman
lambda
chain
catalogu
bd
bioscienc
apcantihuman
igm
catalogu
biolegend
isol
bcell
clone
function
bcr
cell
surfac
clone
identifi
flow
cytometri
bd
facsaria
bd
bioscienc
expand
resort
igm
lightchain
neg
six
gener
use
activ
studi
igmneg
cell
transfect
cell
line
nucleofector
kit
v
lonza
group
wildtyp
cdr
mutat
version
germlin
receptor
igm
twentyfour
hour
transfect
cell
expos
either
mous
antihuman
igm
f
catalogu
southernbiotech
hb
posit
control
ha
proteoliposom
ha
trimer
dilut
hb
min
exposur
room
temperatur
cell
place
wash
two
time
hb
lyse
min
lysi
buffer
cell
lysi
buffer
cell
signal
technolog
supplement
proteas
inhibitor
complet
proteas
inhibitor
cocktail
catalogu
roch
appli
scienc
bcr
activ
assess
western
blot
analysi
cell
lysat
py
catalogu
millipor
reactiv
phosphotyrosin
total
phosphotyrosin
intens
three
independ
experi
measur
densitometri
imag
process
java
imag
j
softwar
curv
area
densiti
calcul
perform
microsoft
excel
phosphotyrosin
intens
standard
level
cell
lysat
actin
monoclon
catalogu
sigma
background
valu
bcr
activ
defin
extent
stimul
untransfect
igmneg
ramo
expos
mous
antihuman
igm
f
fab
fragment
shgl
concentr
mg
pb
crystal
hang
drop
reservoir
contain
mm
imidazol
ph
polyethylen
glycol
crystal
cryoprotect
transfer
paratonen
vitrifi
liquid
nitrogen
data
resolut
collect
southeast
region
collabor
access
team
sercat
beamlin
advanc
photon
sourc
argonn
nation
laboratori
structur
determin
molecular
replac
use
program
phaser
structur
bound
influenza
ha
search
model
refin
use
program
phenix
supplementari
tabl
asymmetr
unit
contain
eight
copi
fab
cdr
delet
model
refin
electron
densiti
map
calcul
model
cdr
show
weak
densiti
correspond
loop
howev
ncsaverag
map
calcul
coot
shown
fig
indic
clearli
cdr
loop
adopt
noncanon
conform
similar
observ
cocryst
structur
ha
